Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Cancer Cell|October 11, 2024
Accelerated approvals: Early-phase success or premature authorization?Xiangyun Mao, G Caleb Alexander, Guanqiao Li
Drug Discovery Today|October 25, 2025
Therapeutic value and regulatory characteristics of breakthrough therapy drugs in the USA and China (2021-2023): a retrospective cohort studyXiangyun Mao, Haoyu Yin, Xiaoyin Bai, et al.
The Lancet Regional Health. Western Pacific|February 19, 2025
Regulatory flexibilities balancing unmet needs, benefits and risks in the approvals of imported cancer drugs in China: a cohort study from 2012 to 2021Xiangyun Mao, Jiachen Xu, Xiaozhen Liu, et al.
Signal Transduction and Targeted Therapy|May 11, 2026
The evolving global landscape of first-in-class oncology drug innovationXiangyun Mao, Zhaoqing Wang, Shu Kong, et al.
Communications Medicine|November 1, 2025
Digital health technology use in clinical trials of rare diseases: a systematic reviewXiangyun Mao, Dian Zeng, Xiaocong Wang, et al.
Pageof 1